InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Monday, 03/18/2019 3:50:41 PM

Monday, March 18, 2019 3:50:41 PM

Post# of 6315
News: $NMUS Nemus Bioscience Reports Nanoemulsion of NB1111 Superior to First-Line Therapy, Latanoprost, in Lowering Intraocular Pressure in Validated Normotensive Animal Model Testing

Prodrug of THC Outperformed Latanoprost at Multiple Timepoints in Multiple Dosing Study NB1111 Formulation Extends Pharmaceutical Activity Time to Support Once-Daily to Twice-Daily Topical Dosing LONG BEACH, CA, March 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nemus Bios...

Read the whole news https://marketwirenews.com/news-releases/nemus-bioscience-reports-nanoemulsion-of-nb1111-superior-to-first-line-therapy-latanoprost-in-lowering-intraocular-pressure-in-validated-normotensive-animal-model-testing-7852692.html